LAURUSLABS price chart
Daily close · 5-year history
Instrument details
Identifiers & classification
- Symbol
- LAURUSLABS
- MB Code
- MBEQU222
- ISIN
- INE947Q01028
- BSE code
- 540222
- Industry group
- Pharmaceuticals & Biotechnology
- Screener
- View peers →
Latest earnings
Most recent declared quarter
- Quarter
- Mar 2026
- Revenue
- 1811.57 Cr
- Net profit
- 281.91 Cr
- EPS
- 5.17
- YoY revenue
- +5.31%
Company documents
12 PDFs across 4 categories
Audited annual reports & financial statements
Earnings call transcripts & Q&A
Investor decks & strategy updates
Exchange filings & corporate announcements
Corporate timeline
Earnings, news & corporate actions for LAURUSLABS
Laurus Labs shares fell after weak Q3 results, with investors debating whether the stock is still worth holding or selling following the …
Dividend of ₹1.20 per share
Ex-date corporate action
Laurus Labs jumped 6% to a record high after Q4 results, with brokerages turning upbeat as CDMO quarterly run rate rose from ₹220-250 cro…
EPS 5.17 vs est. 5.12
Beat estimates by 0.90%
Laurus Labs reported Q4 results with net profit up 19% year-on-year to ₹279 crore, indicating improved profitability for the quarter.
Laurus Labs’ consolidated net profit rose 19.46% in the March 2026 quarter; FY net profit jumped 148.04% to Rs 888.79 crore and sales ros…
Laurus Labs reported strong Q3 results on January 23, 2026, with revenue of ₹1,778.3 crore, up 25.7% year-over-year. EBITDA rose 68% to ₹…
EPS 4.67 vs est. 3.77
Beat estimates by 23.74%
Price returns
Historical performance
Technicals
Indicator consensus